Correlation Between Inhibrx and EvoAir Holdings
Can any of the company-specific risk be diversified away by investing in both Inhibrx and EvoAir Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and EvoAir Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and EvoAir Holdings, you can compare the effects of market volatilities on Inhibrx and EvoAir Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of EvoAir Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and EvoAir Holdings.
Diversification Opportunities for Inhibrx and EvoAir Holdings
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Inhibrx and EvoAir is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and EvoAir Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EvoAir Holdings and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with EvoAir Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EvoAir Holdings has no effect on the direction of Inhibrx i.e., Inhibrx and EvoAir Holdings go up and down completely randomly.
Pair Corralation between Inhibrx and EvoAir Holdings
If you would invest 2,300 in EvoAir Holdings on September 25, 2024 and sell it today you would earn a total of 0.00 from holding EvoAir Holdings or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Inhibrx vs. EvoAir Holdings
Performance |
Timeline |
Inhibrx |
EvoAir Holdings |
Inhibrx and EvoAir Holdings Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Inhibrx and EvoAir Holdings
The main advantage of trading using opposite Inhibrx and EvoAir Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, EvoAir Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EvoAir Holdings will offset losses from the drop in EvoAir Holdings' long position.Inhibrx vs. Fate Therapeutics | Inhibrx vs. Caribou Biosciences | Inhibrx vs. Arcus Biosciences | Inhibrx vs. Karyopharm Therapeutics |
EvoAir Holdings vs. The Joint Corp | EvoAir Holdings vs. Alvotech | EvoAir Holdings vs. Amgen Inc | EvoAir Holdings vs. Viemed Healthcare |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |